Merck and Moderna's cancer vaccine works. Making it affordable is the next test
Merck and Moderna build a custom mRNA vaccine for each melanoma patient from tumor mutations. The strategy stumbles in cancers lacking enough targets
We haven't written up this one. Quartz has the full story — the link below goes straight to it.